Federal Court finds Eli Lilly’s tadalafil dosage form and process patents invalid

Published date05 October 2020
Subject MatterPatents,Obviousness,Eli Lilly,Patent Litigation,Pharmaceutical Patents,Enablement Inquiries,Canada,Patent Infringement,Patent Invalidity,Patent Validity,Anticipation
AuthorChen Li
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT